CAD Therapeutics
CAD Therapeutics is a biopharmaceutical company developing novel therapeutic candidates targeting post-traumatic stress disorder.
Series A ·
Amount not disclosed in a source on record.
Funding history ↓About CAD Therapeutics
CAD Therapeutics is a company based in New York, United States. Recent Funding lists it under Health and bio. Its latest known round is a Series A round (October 2026); no sourced amount is on record for it yet.
Funding rounds
- Series A · amount undisclosed
- Website created
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
CCureBay$10.55M Series B+ · Oct 2026
Questions and sources
CAD Therapeutics: questions and answers
- Where is CAD Therapeutics based?
- CAD Therapeutics is based in New York, United States.
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/cad-therapeutics (get a free API key).